Zurich Cantonal Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Zurich Cantonal Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,761	Closed	-$580K	–	3423
2025 Q4	$580K	Buy	+4,761	New	+$546K	﹤0.01%	1707

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Zurich Cantonal Bank's XBI Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 3,909 shares worth $465K. The stake represents ﹤0.01% of the portfolio and ranks #1867 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in XBI as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in XBI in Q1 2018 and has held it in 30 quarters since. The position peaked at $3.15M in Q4 2020. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Zurich Cantonal Bank held 3,909 shares of State Street SPDR S&P Biotech ETF worth $465K as of Q1 2026.
State Street SPDR S&P Biotech ETF was a new Zurich Cantonal Bank position in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1867 holding.
Zurich Cantonal Bank first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and has held it in 30 quarters since.
Zurich Cantonal Bank's State Street SPDR S&P Biotech ETF position peaked at $3.15M in Q4 2020.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.